HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Occupational asthma due to inhalation of chloramine-T. II. Demonstration of specific IgE antibodies.

Abstract
In the sera of patients who developed asthmatic symptoms after exposure to chloramine-T, specific IgE antibodies are demonstrated by a polystyrene tube radioimmunoassay. These antibodies are directed against human serum albumin treated with chloramine-T. Specific antibodies of subclasses IgG1, IgG3 and IgG4 were not found. Histamine release in response to chloramine-T-treated human serum albumin was demonstrated using the peripheral blood leukocytes of one of the patients. To define the antigenic determinant to which the specific IgE antibodies are directed, radioimmunoassay and radioimmunoassay-inhibition studies were performed using several autologous and heterologous chloramine-T-treated proteins. Moreover, the inhibition capacities of chloramine-T and structurally related compounds were also determined. The results of these experiments indicate that the antigenic determinant is formed, at least in part, by the p-toluenesulfonyl group of the chloramine-T molecule.
AuthorsJ A Kramps, A W van Toorenenbergen, P H Vooren, J H Dijkman
JournalInternational archives of allergy and applied immunology (Int Arch Allergy Appl Immunol) Vol. 64 Issue 4 Pg. 428-38 ( 1981) ISSN: 0020-5915 [Print] Switzerland
PMID6162800 (Publication Type: Journal Article)
Chemical References
  • Chloramines
  • Epitopes
  • Immunoglobulin G
  • Serum Albumin
  • Tosyl Compounds
  • chloramine-T
  • Immunoglobulin E
Topics
  • Adult
  • Antibody Specificity
  • Asthma (etiology, immunology)
  • Binding Sites, Antibody
  • Chloramines (adverse effects, pharmacology)
  • Epitopes
  • Female
  • Histamine Release (drug effects)
  • Humans
  • Immunoglobulin E (immunology)
  • Immunoglobulin G (biosynthesis)
  • Male
  • Occupational Diseases (etiology, immunology)
  • Radioallergosorbent Test
  • Radioimmunoassay
  • Serum Albumin (immunology)
  • Tosyl Compounds

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: